Login/Sign Up
Rasbase 1.5 mg Injection 1's
Rasbase 1.5 mg Injection is used to treat high levels of uric acid (a natural substance that builds up in the blood as tumors break down) in people with certain types of cancer who are being treated with chemotherapy medications. It works by breaking down uric acid so that the body can eliminate it. Rasbase 1.5 mg Injection may cause nausea, vomiting, constipation, diarrhoea, abdominal pain, mouth sores, throat pain, headache, anxiety, joint pain and fever.
₹10496*
MRP ₹12800
18% off
₹10880*
MRP ₹12800
15% CB
₹1920 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Provide Delivery Location
Whats That
Rasbase 1.5 mg Injection is a recombinant version of the enzyme urate oxidase used to reduce uric acid levels in patients with leukaemia, lymphoma, and solid tumor malignancies receiving anti-cancer therapy. Leukaemia, or blood cancer, is a cancer of blood cells or blood-forming tissues. Lymphoma is a cancer of the lymphatic system.
Rasbase 1.5 mg Injection contains Rasburicase, which belongs to the class of recombinant urate-oxidase enzymes. It works by metabolising the recombinant urate oxidase enzyme and thus helps clear the uric acid levels.
Rasbase 1.5 mg Injection may cause certain side effects such as vomiting, nausea, fever, constipation, diarrhoea, oedema, headache, abdominal pain, anxiety, and injection site reactions. Most of these side effects of Rasbase 1.5 mg Injection do not require medical attention and gradually resolve over time. A trained healthcare professional will administer Rasbase 1.5 mg Injection. Hence, do not self-administer.
If you are allergic to Rasbase 1.5 mg Injection, inform your doctor and avoid taking it. Inform your doctor about your complete medical and medication history before starting treatment with Rasbase 1.5 mg Injection. Rasbase 1.5 mg Injection is contraindicated for pregnant women and breastfeeding women due to serious fetal harm. Hence, inform your doctor if you are pregnant or planning to become pregnant. Inform your doctor if you have/had kidney or liver disease.
Rasbase 1.5 mg Injection contains Rasburicase, which belongs to the recombinant urate-oxidase class of drugs. It works directly by metabolising the recombinant urate oxidase enzyme. This converts into allantoin, which is more soluble in urine. It makes it easier for the kidneys to excrete uric acid from the body.
Inform your doctor if you develop any allergic reactions after receiving Rasbase 1.5 mg Injection. Inform your doctor about your complete medical and medication history before starting treatment with Rasbase 1.5 mg Injection. Rasbase 1.5 mg Injection is contraindicated for pregnant women and breastfeeding women due to serious fetal harm. Hence, inform your doctor if you are pregnant or planning to become pregnant. Rasbase 1.5 mg Injection may cause severe hypersensitivity reactions, anaphylactic reactions, methemoglobinemia, and hemolysis in some patients. Hence, inform your doctor if you have/had any pre-existing liver or kidney disease. Avoid alcohol consumption with Rasbase 1.5 mg Injection as it may cause serious side effects. Avoid breastfeeding while receiving Rasbase 1.5 mg Injection as it can cause harm to the baby. This medicine is contraindicated in patients with G6PD deficiency.
Drug-Drug Interactions: No interactions found.
Drug-Food Interactions: Rasbase 1.5 mg Injection may interact with alcohol. Therefore, avoid alcohol consumption with Rasbase 1.5 mg Injection as it may increase the risk of liver damage.
Drug-Disease Interactions: Inform your doctor if you have liver or kidney disease before starting treatment with Rasbase 1.5 mg Injection.
Lymphoma: Lymphoma is a cancer of the lymphatic system, which is the body’s disease-fighting system. It includes lymph nodes, spleen, bone marrow, and thymus.
Leukaemia: Also known as blood cancer, is a cancer of blood cells or blood-forming tissues. It causes excessive production of immature white blood cells by the bone marrow and reduces the body’s ability to fight infections.
Alcohol
Consult your doctor
It is unknown whether Rasbase 1.5 mg Injection interacts with alcohol. Please consult your doctor.
Pregnancy
Unsafe
It is not recommended for use in pregnancy as it may harm your foetus. Hence, if you are pregnant or planning pregnancy, inform your doctor before receiving Rasbase 1.5 mg Injection. You should not become pregnant while on treatment with Rasbase 1.5 mg Injection.
Breast Feeding
Unsafe
It is not recommended for use in breastfeeding as it may pass into breast milk and harm your infant. If you are breastfeeding, inform your doctor before receiving Rasbase 1.5 mg Injection. Your doctor may suggest you stop feeding while on treatment with this medicine.
Driving
Caution
Rasbase 1.5 mg Injection is administered as a single dose in a hospital setting. however Rasbase 1.5 mg Injection may cause dizziness; therefore, avoid driving vehicles or operating machinery until you return to normal.
Liver
Caution
If you have a pre-existing or a history of liver disease, inform your doctor before receiving Rasbase 1.5 mg Injection. Your doctor may adjust the dose of this medicine or prescribe a suitable alternative based on your condition.
Kidney
Caution
If you have a pre-existing or a history of kidney disease, inform your doctor before receiving Rasbase 1.5 mg Injection as it may lead to kidney failure. Your doctor may adjust the dose of this medicine or prescribe a suitable alternative based on your condition.
Children
Safe if prescribed
Please consult your doctor. Rasbase 1.5 mg Injection can be used in children if prescribed.
Country of origin
Product Substitutes